secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001437749-25-025482
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q2 revenue up 13% to $48.6M on Electrochem; margin down, GAAP EPS $0.05 vs $0.18
--------------------------------------------------------------------------------

- Sales $48.6M (+13% YoY); organic Battery & Energy flat, Communications Systems down 57.2% to $2.7M.
- Gross margin fell to 23.9% from 26.9% due to product mix, tariffs, and lower factory throughput.
- Operating income $2.3M vs $3.9M; GAAP EPS $0.05 vs $0.18; adjusted EPS $0.07 vs $0.22.
- Backlog with high-confidence orders $89M vs $95M at Q1 2025; debt prepaid $2.7M.
- CEO expects improved results in H2 2025 on rebound in Communications and new product orders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774925025482/0001437749-25-025482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774925025482/ulbi20250806_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-025482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer